欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/1176/001
药品名称
Lerimamed
活性成分
hydrochlorothiazide 12.5 mg
ramipril 2.5 mg
剂型
Tablet
上市许可持有人
Medochemie Ltd P.O. Box 51409 1-10 Constantinoupoleos Street 3011 Limassol Cyprus
参考成员国 - 产品名称
Denmark (DK)
互认成员国 - 产品名称
Latvia (LV)
Ramipril HCT Medochemie 2,5 mg/12,5 mg tabletes
Lithuania (LT)
Ramimed HCT 2,5 mg/12,5 mg tabletės
Bulgaria (BG)
Ramimed HCT
Cyprus (CY)
RAMIMED HCT 2.5/12.5MG
Czechia (CZ)
Romania (RO)
Ramipril HCT - Medochemie 2,5 mg/12,5 mg
Slovakia (SK)
Ramimed HCT 2,5/12,5 tbl
许可日期
2007/10/05
最近更新日期
2022/11/10
药物ATC编码
C09BA05 ramipril and diuretics
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final SPC
|
1176 common_SmPC_v4_3_Jan_2022_clean
Date of last change:2022/11/10
Final PL
|
1176 common_pil_v4_3_Jan_2022_clean
Date of last change:2022/11/10
Final Labelling
|
label-5-25-clean
Date of last change:2017/11/03
Final Labelling
|
label-2-5-12-5-clean
Date of last change:2017/11/03
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase